CK 19 Expression in Pancreatic Neuroendocrine Tumors as Negative Prognostic Factor and a Risk Factor for Metastases
#239
Introduction: Neuroendocrine tumors (NET) of the pancreas are slow growing neoplasms, but they can metastasize after many years after surgery.
Aim(s): To evaluate the role of cytokeratin 19 (CK 19) expression in NETs of different origin.
Materials and methods: We conducted a comparative study of CK19 expression in 211 NET specimens: pancreas - 118, gut - 35, lung - 21, stomach - 15, thymus - 6, metastases with unknown primary localization -16. Metastases were revealed in 28 cases NET of the pancreas (23,7%), in 15 (42,9%) - gut, in 10 (66,7%) -stomach, in 6 (28,6%) - lung and in 3 (50%) - thymus.
Conference: 8th Annual ENETSConcerence (2011)
Presenting Author:
Authors: Gurevich L, Korsakova N, Kazantseva I, Bobrov M, Egorov A,
Keywords: neuroendocrine tumors, CK19 expression, immunohischemistry, prognosis.,
To read the full abstract, please log into your ENETS Member account.